OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
1-Year Return
4.17%
This Quarter Return
-10.93%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$126M
AUM Growth
+$1.24M
(+0.99%)
Cap. Flow
+$21.4M
Cap. Flow
% of AUM
17.02%
Top 10 Holdings %
Top 10 Hldgs %
41.51%
Holding
66
New
9
Increased
28
Reduced
12
Closed
9
Top Buys
| 1 |
iShares Biotechnology ETF
IBB
|
$6.07M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$3.25M |
| 3 |
Bristol-Myers Squibb
BMY
|
$2.13M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$2.11M |
| 5 |
Merck
MRK
|
$2.03M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$5.35M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$1.76M |
| 3 |
Esperion Therapeutics
ESPR
|
$1.23M |
| 4 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$1.21M |
| 5 |
Pacira BioSciences
PCRX
|
$1.07M |
Sector Composition
| 1 | Healthcare | 85.85% |
| 2 | Financials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Hologic
HOLX
$14.8B
| $1.88M | 1.04% |
48,000
| – | – |
|
|
NSTG
27
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.64M | 0.9% |
102,200
+42,200
| +70% | +$675K |
|
|
ARRY
28
DELISTED
Array Biopharma Inc
ARRY
| $1.14M | 0.63% |
250,000
-70,000
| -22% | -$319K |
|
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.46B
| $926K | 0.51% |
56,788
+5,000
| +10% | +$81.5K |
|
30
Vericel Corp
VCEL
$1.7B
| $900K | 0.5% |
332,157
-30,000
| -8% | -$81.3K |
|
|
ZGNX
31
DELISTED
Zogenix, Inc.
ZGNX
| $887K | 0.49% |
65,700
+28,200
| +75% | +$381K |
|
|
32
Pacira BioSciences
PCRX
$1.2B
| $863K | 0.48% |
21,000
-26,000
| -55% | -$1.07M |
|
33
Amgen
AMGN
$151B
| $778K | 0.43% |
5,626
+76
| +1% | +$10.5K |
|
34
Curis
CRIS
$21.4M
| $756K | 0.42% |
3,745
+1,595
| +74% | +$322K |
|
|
ACHN
35
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $733K | 0.4% |
106,104
+39,400
| +59% | +$272K |
|
36
United Therapeutics
UTHR
$17.2B
| $731K | 0.4% |
5,571
+172
| +3% | +$22.6K |
|
|
STML
37
DELISTED
Stemline Therapeutics, Inc.
STML
| $662K | 0.37% |
75,000
| – | – |
|
|
EPZM
38
DELISTED
Epizyme, Inc
EPZM
| $593K | 0.33% |
46,079
-26,300
| -36% | -$338K |
|
|
CMRX
39
DELISTED
Chimerix, Inc.
CMRX
| $541K | 0.3% |
14,152
-5,000
| -26% | -$191K |
|
|
MACK
40
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $528K | 0.29% |
7,881
-1,271
| -14% | -$85.2K |
|
41
Gilead Sciences
GILD
$140B
| $424K | 0.23% |
4,323
+89
| +2% | +$8.73K |
|
|
SIOX
42
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $397K | 0.22% |
+3,840
| New | +$397K |
|
|
INFI
43
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $383K | 0.21% |
45,300
-34,700
| -43% | -$293K |
|
44
Arrowhead Research
ARWR
$3.87B
| $295K | 0.16% |
51,133
-31,000
| -38% | -$179K |
|
|
ISEE
45
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $290K | 0.16% |
+7,150
| New | +$290K |
|
|
NHLD
46
DELISTED
National Holdings Corporation
NHLD
| $246K | 0.14% |
89,530
| – | – |
|
47
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$723M
| $241K | 0.13% |
+186
| New | +$241K |
|
48
Talphera
TLPH
$10.6M
| $176K | 0.1% |
2,887
-2,111
| -42% | -$129K |
|
49
Karyopharm Therapeutics
KPTI
$58.4M
| $155K | 0.09% |
+983
| New | +$155K |
|
50
Assembly Biosciences
ASMB
$179M
| $143K | 0.08% |
1,250
-4,167
| -77% | -$477K |
|